Literature DB >> 8454477

T1-T2 squamous cell carcinoma of the glottic larynx treated with radiotherapy: a multivariate analysis of variables potentially influencing local control.

D A Fein1, W M Mendenhall, J T Parsons, R R Million.   

Abstract

PURPOSE: To examine various parameters that might influence the probability of local control of T1-T2 glottic carcinoma treated with radiotherapy. METHODS AND MATERIALS: Two hundred forty-seven patients with invasive, previously untreated T1-T2 squamous cell carcinoma of the glottic larynx were treated with radiotherapy between May 1977 and December 1989. All patients had a minimum 2-year follow-up. To minimize treatment-related variables, only patients with T1 lesions treated once daily at 225 cGy per fraction and patients with T2 lesions treated once daily at 225 cGy per fraction or twice daily at 120 cGy per fraction were included. Surgical alternative, thickness of the neck at the posterior edge of the lateral fields, vocal cord mobility, anterior commissure involvement, gender, and T stage were evaluated in a multivariate analysis.
RESULTS: The 5-year local control rates, calculated by the product-limit method, were T1a, 95%; T1b, 96%; T2a, 87%; and T2b, 76%. The 5-year local control rate for patients with T2 lesions treated with once-daily fractionation was 81% compared with 91% for those who received twice-a-day radiotherapy. For the endpoint of local control with irradiation, the surgical alternative (p = .020) and cord mobility (p = .001) were of independent prognostic significance.
CONCLUSION: Of the variables analyzed, only vocal cord mobility and surgical alternative significantly influenced local control. Specifically, anterior commissure involvement and neck thickness did not affect local control.

Entities:  

Mesh:

Year:  1993        PMID: 8454477     DOI: 10.1016/0360-3016(93)90005-g

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  18 in total

1.  Hyperfractionated radiotherapy for T2 glottic cancer for preservation of the larynx.

Authors:  Ichiro Tateya; Shigeru Hirano; Hisayoshi Kojima; Koichi Omori; Kazuhiko Shoji; Michihide Mitsumori; Yasushi Nagata; Juichi Ito
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-07-13       Impact factor: 2.503

2.  [Glottic laryngeal carcinoma. Tis, T1 and T2--long term results after laser resection].

Authors:  O König; U Bockmühl; K Haake
Journal:  HNO       Date:  2006-02       Impact factor: 1.284

3.  Radiotherapy for head and neck cancer.

Authors:  Shyh-An Yeh
Journal:  Semin Plast Surg       Date:  2010-05       Impact factor: 2.314

4.  Prognostic factors for local control in patients receiving radiation therapy for early glottic cancer: anterior commissure involvement and effect of chemoradiotherapy.

Authors:  Yosuke Kitani; Akira Kubota; Madoka Furukawa; Kaname Sato
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-03-01       Impact factor: 2.503

5.  Prospective analysis of functional swallowing outcome after resection of T2 glottic carcinoma using transoral laser surgery and external vertical hemilaryngectomy.

Authors:  Hani Osama Nasef; Hossam Thabet; Cesare Piazza; Francesca Del Bon; Mohamed Eid; Manal El Banna; Piero Nicolai
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-04-27       Impact factor: 2.503

Review 6.  3D conformal hypofractionated radical radiotherapy in early glottic cancer.

Authors:  Ana Cristina Amado; Laurentiu Bujor; Isabel Monteiro Grillo
Journal:  Rep Pract Oncol Radiother       Date:  2013-05-30

7.  Dynamic helical CT of T1 and T2 glottic carcinomas: predictive value for local control with radiation therapy.

Authors:  R Murakami; M Furusawa; Y Baba; R Nishimura; F Katsura; M Eura; K Masuyama; M Takahashi
Journal:  AJNR Am J Neuroradiol       Date:  2000-08       Impact factor: 3.825

8.  CT-scan prediction of thyroid cartilage invasion for early laryngeal squamous cell carcinoma.

Authors:  Dana M Hartl; Guillaume Landry; François Bidault; Stéphane Hans; Morbize Julieron; Gérard Mamelle; François Janot; Daniel F Brasnu
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-03-30       Impact factor: 2.503

Review 9.  Is open surgery for head and neck cancers truly declining?

Authors:  Dana M Hartl; Daniel F Brasnu; Jatin P Shah; Michael L Hinni; Robert P Takes; Kerry D Olsen; Luiz P Kowalski; Juan P Rodrigo; Primož Strojan; Gregory T Wolf; Alessandra Rinaldo; Carlos Suárez; William M Mendenhall; Vinidh Paleri; Arlene A Forastiere; Jochen A Werner; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-01-03       Impact factor: 2.503

Review 10.  Organ preservation surgery for laryngeal cancer.

Authors:  Sharad Chawla; Andrew Simon Carney
Journal:  Head Neck Oncol       Date:  2009-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.